Podcasts

OncLive On Air^® is a podcast from OncLive^® that provides oncology professionals with the resources and information they need to provide the best patient care. Segments cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. New episodes with exclusive interviews with leading oncology experts are released on Mondays and Thursdays.

Tackling Genitourinary Cancer Topics in Chicago

October 3rd 2018

We visited Chicago, Illinois for a State of the Science Summit on Renal Cell Carcinoma and Bladder Cancer. The meeting covered the genomics of bladder cancer, novel approaches to non-muscle invasive bladder cancer, side effect management from immunotherapy, as well as the integration of immunotherapy, chemotherapy, and targeted therapy in genitourinary cancers.

Third Time's a Charm: Sailing to Seattle for More Hematologic Cancer Updates

September 26th 2018

We traveled to Seattle, Washington for another State of the Science Summit on Hematologic Malignancies with faculty of Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center. The meeting covered the latest updates in Hodgkin lymphoma, mantle cell lymphoma, multiple myeloma, and more.

Diving Into Hematologic Diseases in Dearborn

September 19th 2018

We visited Dearborn, Michigan for a State of the Science Summit on Hematologic Malignancies with faculty of Karmanos Cancer Institute.

Taking Lessons From Hematology Experts in Tampa

September 12th 2018

We headed to Tampa, Florida for a State of the Science Summit on Hematologic Malignancies. The meeting covered updates in follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, acute myeloid leukemia, myeloproliferative neoplasms, and CAR T-cell therapy.

Learning the Lung Cancer Landscape in Hanover

September 6th 2018

We traveled to Hanover, Maryland for a State of the Science SummitTM on Advanced Non–Small Cell Lung Cancer. The meeting covered the use of immunotherapy in metastatic and early-stage disease, management of immune-related toxicities, predictive biomarkers, and emerging therapies in small cell lung cancer.

Obtaining the Latest in Ovarian Cancer in Charlotte

August 29th 2018

We traveled to Charlotte, North Carolina for a State of the Science Summit on Ovarian Cancer. The meeting covered genetic testing, frontline therapies, surgical options, treatment for recurrent disease, immunotherapy, and updates in uterine sarcomas.

Expanding on Emerging Agents in GI Cancers in Dallas

August 22nd 2018

This Dallas, Texas meeting on gastrointestinal (GI) cancers covered emerging therapies in pancreatic cancer, updates in neuroendocrine tumors, the management of metastatic colorectal cancer, recent data in hepatocellular carcinoma, and the clinical application of precision medicine in GI cancers.

Navigating Non-Small Cell Lung Cancer Treatment in Charlottesville

August 15th 2018

We traveled to Charlottesville, Virginia for a State of the Science Summit on Advanced Non-Small Cell Lung Cancer. The conference spanned early-stage advances, established and emerging treatments for oncogenic-driven disease, chemotherapy, immunotherapy, and the role of radiation

Advanced Non-Small Cell Lung Cancer Meeting in Denver

August 8th 2018

We went out to Denver, Colorado for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The conference spanned screening, molecular profiling, early-stage advances, treatment for oncogenic-driven advanced disease, and immunotherapy.

Breast Cancer Meeting in Houston

July 24th 2018

We traveled to Houston, Texas for a State of the Science Summit on Breast Cancer on July 11, 2018. The conference covered radiation therapy, triple-negative breast cancer, BRCA-positive tumors, takeaways from the 2018 ASCO Annual Meeting, and more.

2018 ASCO Annual Meeting Recap in Kansas City

July 10th 2018

We headed out to Kansas City, Missouri, for a State of the Science Summit on June 30, 2018, which spanned several tumor types and covered the highlights from the 2018 ASCO Annual Meeting.